CorMedix Inc
Veridion Score
Composite trend over time
Why is CRMD moving today?
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for CRMD.
CRMD insider activity
CorMedix Inc
No multi-insider buying cluster in the last 90 days
Net selling: -$4.3M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-01-27 | 2026-01-23 | Blum Susan | Insider | sell | $7.27 | 9,767 | 132,739 | $71K | SEC Form 4 |
| 2026-01-27 | 2026-01-23 | Zelnick Kaufman Beth | Insider | sell | $7.27 | 8,803 | 233,102 | $64K | SEC Form 4 |
| 2026-01-27 | 2026-01-23 | Hurlburt Elizabeth | Insider | sell | $7.27 | 10,778 | 242,533 | $78K | SEC Form 4 |
| 2026-01-27 | 2026-01-23 | Todisco Joseph | Insider | sell | $7.27 | 27,306 | 697,593 | $199K | SEC Form 4 |
| 2026-01-22 | 2026-01-21 | Dillione Janet | Insider | sell | $6.88 | 10,000 | 38,473 | $69K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 40 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moCRMD contract awards, year to date.
Public federal awards linked to this ticker.
CRMD lobbying filings, year to date.
Registered lobbying filings matched to CorMedix Inc.